Seer, Inc.
NASDAQ:SEERBiotechnology
+$0.01 today
- Market cap
- $77.30M
- Beta
- 1.59
- P/E (TTM)
- -1.4
- EPS (TTM)
- -$1.26
Volume 0.25M
Average 0.32M
Price history
Seer, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-28.61%
Period high
$2.33
Period low
$1.39
Latest
$1.39
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 10, 2026 | Nov 10, 2026 | |
| 8-K | Nov 10, 2026 | Nov 10, 2026 | |
| 4 | Nov 4, 2026 | Nov 4, 2026 | |
| SC 13D | Nov 2, 2026 | Nov 2, 2026 | |
| 8-K | Oct 29, 2026 | Oct 29, 2026 | |
| 3 | Oct 8, 2026 | Oct 8, 2026 | |
| 8-K | Sep 18, 2026 | Sep 18, 2026 | |
| 4 | Aug 19, 2026 | Aug 19, 2026 | |
| 10-Q | Aug 11, 2026 | Aug 11, 2026 | |
| 8-K | Aug 11, 2026 | Aug 11, 2026 | |
| 8-K | Jul 31, 2026 | Jul 31, 2026 | |
| 8-K | Jul 31, 2026 | Jul 31, 2026 | |
| 4 | Jul 30, 2026 | Jul 30, 2026 | |
| 4 | Jul 30, 2026 | Jul 30, 2026 | |
| 4 | Jul 30, 2026 | Jul 30, 2026 |
Competitors
Who does Seer, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Kymera Therapeutics, Inc.
NASDAQ:KYMR
Market cap
$10.89B
Pharvaris N.V.
NASDAQ:PHVS
Market cap
$2.34B
Nurix Therapeutics, Inc.
NASDAQ:NRIX
Market cap
$1.69B
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
Market cap
$1.36B
ORIC Pharmaceuticals, Inc.
NASDAQ:ORIC
Market cap
$814.71M
Monte Rosa Therapeutics, Inc.
NASDAQ:GLUE
Market cap
$800.67M
Cullinan Therapeutics, Inc.
NASDAQ:CGEM
Market cap
$667.39M
Sana Biotechnology, Inc.
NASDAQ:SANA
Market cap
$605.26M
Shattuck Labs, Inc.
NASDAQ:STTK
Market cap
$473.57M
C4 Therapeutics, Inc.
NASDAQ:CCCC
Market cap
$362.43M
Lyell Immunopharma, Inc.
NASDAQ:LYEL
Market cap
$351.57M
PepGen Inc.
NASDAQ:PEPG
Market cap
$301.98M
Quantum-Si incorporated
NASDAQ:QSI
Market cap
$229.78M
AN2 Therapeutics, Inc.
NASDAQ:ANTX
Market cap
$172.64M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
Market cap
$124.12M
Molecular Partners AG
NASDAQ:MOLN
Market cap
$112.71M
Nkarta, Inc.
NASDAQ:NKTX
Market cap
$85.23M
MediciNova, Inc.
NASDAQ:MNOV
Market cap
$68.66M
Questions
Filing questions
Common questions about SEER's filings, answered from its disclosures.
What is the latest SEER filing?
The latest filing shown is 10-Q dated Nov 10, 2026.
How many recent filings does SEER have?
Intrinsic Alpha currently shows 20 recent filings for SEER.
Continue the stock analysis
Jump to another research area for this company.